SCHEMBL7607955

SCHEMBL7607955

O=C(NCC(F)(F)F)OC1(CCCCN2CCN(c3nc4ccccc4s3)CC2)c2ccccc2Oc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
POLB P06746 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK1 P28482 1/20 0.41
DRD2 P14416 4/20 0.40
DRD3 P35462 2/20 0.40
HTR1A P08908 2/20 0.40
HTR2A P28223 2/20 0.40
HTR7 P34969 2/20 0.40
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7597253 0.97 DRD3 (0.41) NPC1RAB9ALMNAMAPTSMN1; SMN2
SCHEMBL7598388 0.89 NPC1 (0.44) NPC1RAB9ALMNAMAPTSMN1; SMN2
SCHEMBL6772766 0.88 MTTP (0.45) NPC1RAB9ALMNAMAPTSMN1; SMN2
SCHEMBL6770501 0.85 MTTP (0.43) NPC1RAB9ALMNAMAPTSMN1; SMN2
SCHEMBL7603486 0.84 ALDH1A1 (0.41) LMNAMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL7608953 0.84 DRD3 (0.38) DRD2DRD3HTR1AHTR2AHTR2C
SCHEMBL7596525 0.83 NPC1 (0.46) NPC1RAB9ALMNAMAPTSMN1; SMN2
SCHEMBL7595966 0.82 RAB9A (0.45) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL7593157 0.82 NPC1 (0.45) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL7600196 0.82 DRD3 (0.44) DRD2DRD3HTR1AHTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255736-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) Boehringer Ingelheim Pharma KG (DE) 2002-11-13 EP disclosed
WO-2001047898-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-07-05 WO disclosed